Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125194022 | 12519402 | 2 | F | 20140605 | 20160713 | 20160630 | 20160719 | EXP | TW-SA-2016SA113544 | AVENTIS | CHONG C-H, LAI G-M, LIN J-T. CENTRAL PONTINE MYELINOLYSIS (CPM) AND EXTRAPONTINE MYELINOLYSIS (EPM) FOLLOWING CONCURRENT CHEMORADIOTHERAPY FOR NASOPHARYNGEAL CARCINOMA. JOURNAL OF CANCER RESEARCH AND PRACTICE 2016 JUN;3(2):58-62. AVAILABLE FROM: HTTP://DX.DOI.ORG/10.1016/J.JCRPR.2015.08.001. ACCESSED: 2016 MAR 21. | 50.00 | YR | A | F | Y | 0.00000 | 20160719 | MD | TW | TW |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125194022 | 12519402 | 1 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | ON DAY 1, SINGLE 6-H INFUSION | U | UNK | 0 | 80 | MG/M**2 | /month | |||||
| 125194022 | 12519402 | 2 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | ON DAY 1, SINGLE 6-H INFUSION | U | UNK | 0 | 80 | MG/M**2 | /month | |||||
| 125194022 | 12519402 | 3 | PS | DOCETAXEL. | DOCETAXEL | 1 | Unknown | SINGLE 1 H INFUSION ON DAY 1 | U | UNK | 20449 | 60 | MG/M**2 | /month | |||||
| 125194022 | 12519402 | 4 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | CONTIONOUS PUMP FROM DAY 1 -4 | U | UNK | 0 | 800 | MG/M**2 | /month | |||||
| 125194022 | 12519402 | 5 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | CONTIONOUS PUMP FROM DAY 1 -4 | U | 0 | 800 | MG/M**2 | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125194022 | 12519402 | 1 | Nasopharyngeal cancer stage I |
| 125194022 | 12519402 | 2 | Nasopharyngeal cancer stage I |
| 125194022 | 12519402 | 3 | Nasopharyngeal cancer stage I |
| 125194022 | 12519402 | 4 | Nasopharyngeal cancer stage I |
| 125194022 | 12519402 | 5 | Nasopharyngeal cancer stage I |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125194022 | 12519402 | HO |
| 125194022 | 12519402 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125194022 | 12519402 | Dizziness | |
| 125194022 | 12519402 | Febrile neutropenia | |
| 125194022 | 12519402 | Hyponatraemia | |
| 125194022 | 12519402 | Irritability | |
| 125194022 | 12519402 | Osmotic demyelination syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |